Company intelligence / Profile preview

E-Scopics

Ownership: Private
Employees: ~16
Development stage: Commercial

Overview

E‑Scopics’ Hepatoscope device has received FDA clearance and CE mark. It provides real-time quantitative assessment of the liver at the point of care using non-invasive ultrasound-based measurements. Clinical results support its use for screening and monitoring MASLD/MASH and other chronic hepatic conditions. The company’s technology enables premium diagnostic performance in an ultraportable form factor suitable for both specialist and primary care settings.

Therapeutic areas: Metabolic DisordersPulmonologyImmunologyGastroenterologyInfectious Diseases
Modalities: Device (Ultrasound-based diagnostic device)Software (Ultrasound-as-a-Service platform)
Industry: Medical Imaging

Drug pipeline

1 asset

Hepatoscope

Commercial

Indications: Non-alcoholic steatohepatitis (NASH), Fatty liver disease, Chronic liver diseases

Partnerships

Gilead Sciences provided seed fundingpartnership with North Carolina State University on pulmonary app developmentlicensing deal with undisclosed industry partner for a specific DR application.

Beyond the preview

Go deeper on E-Scopics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on E-Scopics.

Explore the full profile